These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 20846388

  • 1. Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission.
    Zakeri S, Mehrizi AA, Zoghi S, Djadid ND.
    Malar J; 2010 Sep 16; 9():257. PubMed ID: 20846388
    [Abstract] [Full Text] [Related]

  • 2. IgG subclass antibodies to three variants of Plasmodium falciparum merozoite surface protein-1 (PfMSP-1(19)) in an area with unstable malaria transmission in Iran.
    Mehrizi AA, Asgharpour S, Salmanian AH, Djadid ND, Zakeri S.
    Acta Trop; 2011 Aug 16; 119(2-3):84-90. PubMed ID: 21609709
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
    Rouhani M, Zakeri S, Mehrizi AA, Djadid ND.
    Malar J; 2015 Feb 05; 14():58. PubMed ID: 25652589
    [Abstract] [Full Text] [Related]

  • 4. Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates.
    Mamillapalli A, Sunil S, Diwan SS, Sharma SK, Tyagi PK, Adak T, Joshi H, Malhotra P.
    Malar J; 2007 Jul 20; 6():95. PubMed ID: 17659072
    [Abstract] [Full Text] [Related]

  • 5. Human IgG subclass antibodies to the 19 kilodalton carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP1(19)) and predominance of the MAD20 allelic type of MSP1 in Uganda.
    Apio B, Nalunkuma A, Okello D, Riley E, Egwang TG.
    East Afr Med J; 2000 Apr 20; 77(4):189-93. PubMed ID: 12858901
    [Abstract] [Full Text] [Related]

  • 6. Plasmodium falciparum: sequence analysis of the gene encoding the C-terminus region of the merozoite surface protein-1, a potential malaria vaccine antigen, in Iranian clinical isolates.
    Mehrizi AA, Zakeri S, Salmanian AH, Sanati MH, Djadid ND.
    Exp Parasitol; 2008 Mar 20; 118(3):378-85. PubMed ID: 18053992
    [Abstract] [Full Text] [Related]

  • 7. The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen.
    Sutton PL, Clark EH, Silva C, Branch OH.
    Malar J; 2010 Jan 04; 9():3. PubMed ID: 20047674
    [Abstract] [Full Text] [Related]

  • 8. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.
    Shi YP, Sayed U, Qari SH, Roberts JM, Udhayakumar V, Oloo AJ, Hawley WA, Kaslow DC, Nahlen BL, Lal AA.
    Infect Immun; 1996 Jul 04; 64(7):2716-23. PubMed ID: 8698500
    [Abstract] [Full Text] [Related]

  • 9. Analysis of Fcgamma receptor IIa (cd32) gene polymorphism and anti-malarial IgG subclass antibodies to asexual blood-stage antigen of Plasmodium falciparum in an unstable malaria endemic area of Iran.
    Zakeri S, Mashhadi R, Mehrizi AA, Djadid ND.
    Exp Parasitol; 2013 May 04; 134(1):115-21. PubMed ID: 23458236
    [Abstract] [Full Text] [Related]

  • 10. Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24.
    Gupta PK, Mukherjee P, Dhawan S, Pandey AK, Mazumdar S, Gaur D, Jain SK, Chauhan VS.
    Clin Vaccine Immunol; 2014 Jun 04; 21(6):886-97. PubMed ID: 24789797
    [Abstract] [Full Text] [Related]

  • 11. Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission.
    Torres KJ, Clark EH, Hernandez JN, Soto-Cornejo KE, Gamboa D, Branch OH.
    Malar J; 2008 Sep 09; 7():173. PubMed ID: 18782451
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM, Miura K, Sullivan J, Long CA, Barnwell JW.
    Malar J; 2016 Mar 15; 15():159. PubMed ID: 26975721
    [Abstract] [Full Text] [Related]

  • 13. Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: immunogenicity determined with human-compatible adjuvants and induction of protective immune response.
    Mazumdar S, Mukherjee P, Yazdani SS, Jain SK, Mohmmed A, Chauhan VS.
    Infect Immun; 2010 Feb 15; 78(2):872-83. PubMed ID: 19933832
    [Abstract] [Full Text] [Related]

  • 14. Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.
    Zakeri S, Babaeekhou L, Mehrizi AA, Abbasi M, Djadid ND.
    Am J Trop Med Hyg; 2011 Jun 15; 84(6):944-50. PubMed ID: 21633032
    [Abstract] [Full Text] [Related]

  • 15. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia.
    Okech BA, Corran PH, Todd J, Joynson-Hicks A, Uthaipibull C, Egwang TG, Holder AA, Riley EM.
    Infect Immun; 2004 Mar 15; 72(3):1557-67. PubMed ID: 14977962
    [Abstract] [Full Text] [Related]

  • 16. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R, Varela ML, Joos C, Diouf B, Sokhna C, Mbengue B, Tall A, Loucoubar C, Touré A, Mercereau-Puijalon O.
    Vaccine; 2017 Dec 04; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [Abstract] [Full Text] [Related]

  • 17. Broadly reactive antibodies specific for Plasmodium falciparum MSP-1(19) are associated with the protection of naturally exposed children against infection.
    Dent AE, Moormann AM, Yohn CT, Kimmel RJ, Sumba PO, Vulule J, Long CA, Narum DL, Crabb BS, Kazura JW, Tisch DJ.
    Malar J; 2012 Aug 21; 11():287. PubMed ID: 22909378
    [Abstract] [Full Text] [Related]

  • 18. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
    Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG.
    Infect Immun; 2009 Mar 21; 77(3):1165-74. PubMed ID: 19139189
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants.
    Sachdeva S, Mohmmed A, Dasaradhi PV, Crabb BS, Katyal A, Malhotra P, Chauhan VS.
    Vaccine; 2006 Mar 15; 24(12):2007-16. PubMed ID: 16377036
    [Abstract] [Full Text] [Related]

  • 20. Naturally acquired antibodies to merozoite surface protein (MSP)-1(19) and cumulative exposure to Plasmodium falciparum and Plasmodium vivax in remote populations of the Amazon Basin of Brazil.
    Ladeia-Andrade S, Ferreira MU, Scopel KK, Braga EM, Bastos Mda S, Wunderlich G, Coura JR.
    Mem Inst Oswaldo Cruz; 2007 Dec 15; 102(8):943-51. PubMed ID: 18209933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.